OSE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - OSE Immunotherapeutics SA

Watchlist Manager

Watchlist

Price: 2.004 EUR -1.86%

Market Cap: €47.2m

	OSE Immunotherapeutics SA PAR:OSE	FR
D	Dae Hwa Pharm Co Ltd KOSDAQ:067080	KR
	Centaurus Metals Ltd ASX:CTM	AU
	Kingfisher PLC F:KFI1	UK
A	Ainsworth Game Technology Ltd ASX:AGI	AU
	Cleantech Vanadium Mining Corp XTSX:CTV	CA

Profitability Summary

OSE Immunotherapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 359%

Negative 3Y Average Operating Margin

-777%

Declining Operating Margin

-811% > -1 359%

Negative Net Margin

-1 401%

Negative 3Y Average Net Margin

-781%

Declining Net Margin

-769% > -1 401%

Negative Free Cash Flow Margin

-1 268%

Negative 3Y Average Free Cash Flow Margin

-744%

Declining Free Cash Flow Margin

-784% > -1 268%

Negative ROE

-82%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3%

Declining ROIC

-51% > -70%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.